Report Categories
View AllRecent Articles
View All
KOYNU CSLM quarterly earnings financial metrics remain pending ahead of its scheduled investor call next month
JFBRW Jeffs quarterly earnings metrics not yet public with leadership set to share strategic outlook and results soon
APAM Artisan notches 139 percent Q4 2025 EPS beat but shares drop 089 percent in daily trading
Is Willow WLAC stock expensive compared to peers WLAC Latest Quarter Earnings Willow posts no operating results advances deSPAC plans
US DOJ Indicts Four Chinese Container Manufacturers Alleging PandemicEra PriceFixing Cartel
International Court Ruling on Indus Waters Treaty Backs Pakistans Stance
JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Resilience
BlackSky BKSY Stock Analysis Climbs 091 Eyes on 4786 20260520
Vestas Wind Systems Shares Decline After Margin Guidance Warning
European Markets Reach OneMonth High on Tech Sector Strength and Geopolitical Optimism
Spotify Surges on AI Deal with Universal Music and LongTerm Revenue Guidance
Consumer Credit Growth Accelerates in December Amid Holiday Spending Surge
Government Plans Up to 2 LIC Stake Sale Potentially Raising Rs 10000 Crore
SpaceX Scrubs Starship Test Flight Reschedules for Friday Amid V3 Debut
NextPlat Corp NXPL Q1 2026 Earnings EPS Loss of 042 No Revenue Disclosed Stock Rises 499
GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135
BZH Q1 2026 Earnings Strong EPS Surprise as Loss Narrows
DKNG Q1 2026 Earnings EPS Surprises to the Upside as DraftKings Narrows Losses
Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress
VABK Q1 2026 Earnings Reported EPS of 097 Drives Positive Stock Movement
Diversified Healthcare Trust DHC Slips 169 Navigating Key Support Levels
Crown Holdings Inc CCK Holds Steady Near MidRange as Trading Volume Moderates
Central Securities Corporation CET Edges Higher Approaching Resistance in a Steady Advance
Crane Company CR Gains 248 as Price Holds Above Key Support Level
BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support